Latest Updates
Read the latest news that impacts the oncology community.
5 takeaways as RFK Jr. battles GOP, Democratic senators on CDC, vaccines
Robert F. Kennedy Jr. defended his tenure as the nation’s top health official during a contentious Senate hearing Thursday, snapping back at lawmakers who pressed him on the recent upheaval at the Centers for Disease Control and Prevention (CDC) and changes to vaccine policy.
Read MoreBlue states eye rival health rules to defy RFK Jr.
Blue states are quickly moving to defy Health Secretary Robert F. Kennedy Jr.'s vaccine restrictions, increasing the likelihood of a patchwork of conflicting policies similar to the divides over abortion and gender-affirming care.
Read MoreDrug Makers And Payers To Blame For Biosimilar Barriers In U.S. Market
If there is one thing that all stakeholders in the prescription drug supply chain can agree on it’s that patients’ out-of-pocket costs for many branded medicines can be prohibitively high.
Read MoreThis Week in 340B: August 26 – September 1, 2025
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country.
Read MoreCMS Mailing Restrictions and Their Impact on Oncology Care Delivery
In this interview, David Eagle, MD, Chair of Legislative Affairs and Patient Advocacy, discusses the Centers for Medicare & Medicaid Services (CMS) policy that prohibits community oncology practices from mailing oral cancer therapies or allowing family members to pick them up.
Read MoreMost Favored Nations
When US policymakers propose copying drug prices from other countries, they offer a simple solution: If other countries secure lower drug prices, why shouldn't the US adopt those prices?
Read MoreReclaiming Medical Professionalism In An Era Of Corporate Healthcare
Medicine's increasing corporatization has fundamentally altered how physicians practice, yet discussions of medical professionalism often remain anchored in frameworks from decades past.
Read MorePhRMA launches ad campaign targeting 340B drug discount program
The Pharmaceutical Research and Manufacturers of America, a drugmaker lobbying group, has launched an advertisement campaign that takes aim at the 340B Drug Pricing Program.
Read MoreUnitedHealth data analytics unit sued over $4.4M factoring loss
A bank in California is suing UnitedHealth and a UnitedHealth data analytics unit, OptumInsight, over losses allegedly caused by a former employee who helped set up a fraudulent scheme that used OptumInsight accounts receivable to get money from providers of factoring arrangements, or arrangements that provide financing backed by the cash the borrowers expect to get from customers.
Read MoreEversana CEO bets $6B on PBM crackdown
Eversana CEO Mark Thierer is backing his contrarian view of the pharmacy benefit manager market with a $6 billion bid to shake it up.
Read More